An Epstein-Barr virus-associated superantigen

Journal of Experimental Medicine

Volumn 184, Issue 3, 1996, Pages 971-980

  Sutkowski, Natalie ^a,c   Palkama, Tessa ^a   Ciurli, Cristina ^b   Sekaly, Rafick Pierre ^b   Thorley Lawson, David A ^a   Huber, Brigitte T ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUPERANTIGEN; VIRUS ANTIGEN;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; INFECTIOUS MONONUCLEOSIS; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS CELL TRANSFORMATION;

EID: 0029835518     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.3.971     Document Type: Article

References (52)

1. Miller, G. 1990. EBV biology, pathogenesis and medical aspects. In Virology. B.N. Fields and D.M. Knipe, R.M. Chanock, M.S. Hirsch, J.L. Melnick, T.P. Monack, and B. Roizman, editors. Raven Press, Ltd., New York. 1921-1958.
2. Kieff, E. 1996. Epstein-Barr virus and its replication. In Fundamental Virology. 3rd ed. B.N. Fields, D.M. Knipe, and P.M. Howley, editors. Lippincott-Raven Publishers, Philadelphia, PA. 1109-1162.
3. Tomkinson, B.E., R. Maziarz, and J.L. Sullivan. 1989. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis. J. Immunol. 143:660-670.
4. Herman, A., J.W. Kappler, P. Marrack, and A.M. Pullen. 1991. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745-772.
5. Lukacher, A.E., Y. Ma, J.P. Carroll, S.R. Abromson-Leeman, J.C. Laning, M.E. Dorf, and T.L. Benjamin. 1995. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J. Exp. Med. 181:1683-1692.
6. Beutner, U., E. Kraus, D. Kitamura, K. Rajewsky, and B.T. Huber. 1994. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179:1457-1466.
7. Golovkina T.V., A. Chervonsky, J.P. Dudley, and S.R. Ross. 1992. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell. 69:637-645.
8. Held, W., G.A. Wanders, A.N. Shakhow, L. Scarpellino, H. Acha-Orbea, and H.R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell. 74: 529-540.
9. Miller, G., and N. Lipman. 1973. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA. 70:190-194.
10. Baer, R., A.T. Bankier, M.D. Biggin, P.L. Deininger, P.J. Farrell, T.J. Gibson, G. Hatfull, G.S. Hudson, S.C. Satchwell, C. Seguin, P.S. Tuffnell, and B.G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (Lond.). 310:207-211.
11. Calender A., M. Billaud, J.P. Aubry, J. Banchereau, M. Vuillaume, and G.M. Lenoir. 1987. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc. Natl. Acad. Sci. USA. 84:8060-8064.
12. Accolla, R.S., R.P. Sekaly, A.P. McDonald, G. Corte, N. Gross, and S. Carrel. 1982. Demonstration at the single-cell level of the existence of distinct clusters of epitopes in two predefined human la molecular subsets. Eur. J. Immunol. 12: 166-169.
13. Brennan, F.M., S. Allard, M. Londei, C. Savill, A. Boylston, S. Carrel, R.N. Maini, and M. Feldmann. 1988. Heterogeneity of T cell receptor idiotypes in rheumatoid arthritis. Clin. Exp. Immunol. 73:417-423.
14. Takahashi, S., H.T. Maecker, and R. Levy. 1989. DNA fragmentation and cell death mediated by T cell antigen receptor/CD3 complex on a leukemia T cell line. Eur. J. Immunol. 19:1911-1919.
15. Posnett, D.N., A. Gottlieb, J.B. Bussel, S.M. Friedman, N. Chiorazzi, Y. Li, P. Szabo, N.R. Farid, and M.A. Robinson. 1988. T cell antigen receptors in autoimmunity. J. Immunol. 141:1963-1969.
16. Carrel, S., P. Isler, M. Schreyer, A. Vacca, S. Salvi, L. Giuffre, and J. Mach. 1986. Expression on human thymocytes of the idiotypic structures from two leukemia T cell lines Jurkat and HPB-ALL. Eur. J. Immunol. 16:649-652.
17. Posnett, D.N., R.D. Bigler, Y. Bushkin, D.E. Fisher, C.Y. Wang, L.F. Mayer, N. Chiorazzi, and H.G. Kunkel. 1984. T cell antiidiotypic antibodies reveal differences between two human leukemias. J. Exp. Med. 160:494-505.
18. Choi, Y.W., B. Kotzin, J. Lafferty, J. White, M. Pigeon, R. Kubo, J. Kappler, and P. Marrack. 1991. A method for production of antibodies to human T-cell receptor beta-chain variable regions. Proc. Natl. Acad. Sci. USA. 88:8357-8361.
19. Leo, O., M. Foo, D.H. Sachs, L.E. Samelson, and J.A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA. 84: 1374-1378.
20. Choi, Y.W., A. Herman, D. DiGiusto, T. Wade, P. Marrack, and J. Kappler. 1990. Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens. Nature (Lond.). 346:471-473.
21. Wei, S., P. Charmley, M.A. Robinson, and P. Concannon. 1994. The extent of the human germline T-cell receptor V beta gene segment repertoire. Immunogenetics. 40:27-36.
22. Blank, U., B. Boitel, D. Mege, M. Ermonval, and O. Acuto. 1993. Analysis of tetanus toxin peptide/DR recognition by human T cell receptors reconstituted into a murine T cell hybridoma. Eur. J. Immunol. 23:3057-3065.
23. Long, E.O., S. Rosen-Bronson, D.R. Karp, M. Malnati, R.P. Sekaly, and D. Jaraquemada. 1991. Efficient cDNA expression vectors for stable and transient expression of HLA-DR in transfected fibroblast and lymphoid cells. Hum. Immunol. 31:229-235.
24. Kappler, J.W., B. Skidmore, J. White, and P. Marrack. 1981. Antigen-inducible, H-2-restricted, interleukin, 2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J. Exp. Med. 153:1198-1214.
25. zur Hausen, H., F. O'Neill, and U. Freese. 1978. Persisting oncogenic herpesvirus induced by the tumor promoter TPA. Nature (Lond.). 272:373-375.
26. Hara, T., L.K.L. Jung, J.M. Bjorndahl, and S.M. Fu. 1986. Human T cell activation. III. Rapid induction of a phosphorylated 28-kD/32-kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens. J. Exp. Med. 164:1988-2005.
27. ++] and activation of PKC. J. Immunol. 142:1854-1860.
28. Marrack, P., and J. Kappler. 1990. The Staphylococcal enterotoxins and their relatives. Science (Wash. DC). 248:705-711.
29. Waller, E.K., M.A. Sen, O.W. Kamel, G.A. Hansteen, M.R. Schick, and I.L. Weissman. 1992. Human T-cell development in SCID-hu mice: Staphylococcal enterotoxins induce specific clonal deletions, proliferation, and anergy. Blood. 80: 3144-3156.
30. Miyashita, E.M., B. Yang, K.M. Lam, D.H. Crawford, and D.A. Thorley-Lawson. 1995. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell. 80:593-601.
31. v. Knebel Doeberitz, M., G.W. Bornkamm, and H. zur Hausen. 1983. Establishment of spontaneously outgrowing lymphoblastoid cell lines with cyclosporin A. Med. Microbiol. Immunol. 172:87-99.
32. Thorley-Lawson, D.A., L. Chess, and J.L. Strominger. 1977. Suppression of in vitro Epstein-Barr virus infection. A new role for adult human lymphocytes. J. Exp. Med. 146:495-508.
33. Moss, D.J., A.B. Rickinson, and J.H. Pope. 1978. Long-term T cell-mediated immunity in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int. J. Cancer. 22:662-668.
34. Veronese, M.L., A. Veronesi, E. D'Andrea, A. Del Mistro, S. Indraccolo, M.R. Mazza, M. Mion, R. Zamarchi, C. Menin, M. Panozzo, A. Amadori, and L. Chieco-Bianchi. 1992. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation. J. Exp. Med. 176:1763-1767.
35. Veronese, M.L., A. Veronesi, L. Bruni, V. Coppola, E. D'Andrea, M.A. Del, S. Mezzalira, M. Montagna, G. Ruffatto, A. Amadori, et al. 1994. Properties of tumors arising in SCID mice injected with PBMC from EBV-positive donors. Leukemia. 8(Suppl)1:s214-217.
36. Veronesi, A., V. Coppola, M.L. Veronese, C. Menin, L. Bruni, E. D'Andrea, M. Mion, A. Amadori, and L. Chieco-Bianchi. 1994. Lymphoproliferative disease in human peripheral-blood-mononuclear-cell-injected SCID mice. II. Role of host and donor factors in tumor generation. Int. J. Cancer. 59:676-683.
37. Rochford, R., and D.E. Mosier. 1995. Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes. J. Virol. 69:150-155.
38. Khanna, R., S.R. Burrows, and D.J. Moss. 1995. Immune regulation in Epstein-Barr virus associated diseases. Microbiol. Rev. 59:387-405.
39. Moss, D.J., S.R. Burrows, J.D. Baxter, and M.F. Livin. 1991. T cell-T cell killing is induced by specific epitopes: evidence for an apoptotic mechanism. J. Exp. Med. 173:681-686.
40. + T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood. 80:452-458.
41. Le Bon, A., C. Desaymard, and M. Papiernik. 1995. Neonatal impaired response to viral superantigen encoded by MMTV (SW) and Mtv-7. Int. Immunol. 7:1897-1903.
42. Saito, I., B. Servenius, T. Compton, and R.I. Fox. 1989. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J. Exp. Med. 169:2191-2198.
43. Sumida, T., F. Yonaha, T. Maeda, E. Tanabe, T. Koike, H. Tomioka, and S. Yoshida. 1992. T cell receptor repertoire of infiltrating T cells in lips of Sjogren's syndrome patients. J. Clin. Invest. 89:681-685.
44. Yonaha, F., T. Sumida, T. Maeda, H. Tomioka, T. Koike, and S. Yoshida. 1992. Restricted junctional usage of T cell receptor V beta 2 and V beta 13 genes, which are overrepresented on infiltrating T cells in the lips of patients with Sjogren's syndrome. Arthritis Rheum. 35:1362-1367.
45. Sumida, T., T. Sakamaki, F. Yonaha, T. Maeda, T. Namekawa, Y. Nawata, K. Takabayashi, I. Iwamoto, and S. Yoshida. 1994. HLA-DR alleles in patients with Sjogren's syndrome over-representing V beta 2 and V beta 13 genes in the labial salivary glands. Br. J. Rheumatol. 33:420-424.
46. Dobrescu, D., B. Ursea, M. Pope, A.S. Asch, and D.N. Posnett. 1995. Enhanced HIV-1 replication in V β 12 T cells due to human cytomegalovirus in monocytes: evidence for a putative herpesvirus superantigen. Cell. 82:753-763.
47. + T cells of the virus-positive twins. Proc. Natl. Acad. Sci. USA. 91:1529-1533.
48. Van Kuyk, R., and D.E. Mosier. 1995. Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines. Virology. 209:643-648.
49. + cytotoxic T cells express CD38 and HLA-DR antigens. J. Immunol. 150:3070-3079.
50. + T cells from HIV-infected persons. J. Immunol. 153:412-420.
51. Astrin, S.M., and J. Laurence. 1992. Human immunodeficiency virus activates c-myc and Epstein-Barr virus in human B lymphocytes. Ann. NY Acad. Sci. 651:422-432.
52. - T cells: sign of a possible role for herpes viruses as cofactors? Blood. 86:1400-1407.